Off-the-Shelf Engineered Liver Tissue Reverses Acute Liver Failure Without Immunosuppression
Raggi, C.; Lapierre, P.; M'Callum, M.-A.; Pham, Q. T.; Selleri, S.; Paun, R. A.; Baratang, N.; Mangahas, C. L.; Benabdallah, B.; Moquin-Beaudry, G.; Park, J.; Dal Soglio, D.; Theoret, Y.; Schwartz, R. E.; Beausejour, C.; Haddad, E.; Paganelli, M.
Show abstract
There is an urgent need for effective solutions to replace liver functions in patients with acute liver failure (ALF). We describe here a human engineered liver tissue composed of induced pluripotent stem cell (iPSC)-derived liver organoids encapsulated within a non-degradable biomaterial. Unlike most stem cell-derived products, this encapsulated liver tissue (ELT) achieves functional maturation during manufacturing. When transiently implanted into the peritoneal cavity of immunocompetent mice with ALF, the human ELT improves survival, treats hepatic encephalopathy and promotes liver regeneration, without requiring immunosuppression. Based on robust processes and designed to overcome challenges such as foreign body reaction, loss of function and cryopreservation, the ELT does not require vascularization and provides immediate and long-lasting functional replacement. Once the liver regenerated, the ELT is explanted, leaving the subjects cured. Macroencapsulation prevents rejection by shielding the organoids from the host immune system, and minimizes the risk of tumorigenicity. The data shown demonstrate the ELTs potential to be developed into a safe and effective off-the-shelf treatment that, if validated in upcoming clinical trials, could replace liver transplantation for many patients with ALF.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A fully defined pluripotent stem cell derived multi-liver-cell model for steatohepatitis and fibrosis 95%
- Custom-engineered hydrogels for delivery of human iPSC-derived neurons into the injured cervical spinal cord 94%
- Recapitulating apicobasal tissue polarity in extracellular matrix incorporated airway organoids 94%
Similar papers in this journal
- A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis 96%
- Paracrine Factor Local Gradient-Generating System for Engineering Perfusable Vascularized Hepatocyte Tissues with Perfusion-Induced Proliferation 95%
- Viscoelastic Notch Signaling Hydrogel Induces Liver Bile Duct Organoid Growth and Morphogenesis 95%
Similar papers in this journal
- Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure 96%
- Mechano-modulatory synthetic niches for liver organoid derivation 96%
- Harnessing the power of whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation 94%
Similar papers in this journal
- Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury 94%
- Emodin-Enhanced hUC-MSC Extracellular Vesicles Alleviate Acute Pancreatitis by Targeting Inflammation and Pyroptosis 92%
- Drug metabolism activity is a Critical Intrinsic Selector for Hepatocytes to elongate cell lifespan by using a cell-killing antibiotic 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.